-transparent.png){kind=logo}
Controversy exists about the suitability of blood from autologous donors for homologous use. We compared the infectious disease test results of 426 autologous donors, designated by donor history as suitable for homologous use, to those of 86,138 volunteer donations collected over the same 5 month period. Although donor characteristics differed, the relative risk of a positive test for anti-HBc in the autologous group was 2.09. When 413 autologous donors were compared to 413 volunteer donors matched for age, sex, and zip code, the relative risk of a positive test for anti-HBc in the autologous group was 3.2. If anti-HBc is a marker for non-A, non-B hepatitis transmissibility, then our autologous group is not as safe as our volunteer donors. We recommend that autologous blood, even when designated by donor history and laboratory screening results as suitable for homologous transfusion, not be used for other than the intended autologous recipient.
B J Grossman, and
N C Stewart, and
A J Grindon
August 1976,
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
B J Grossman, and
N C Stewart, and
A J Grindon
January 1987,
Transfusion,
B J Grossman, and
N C Stewart, and
A J Grindon
January 1981,
Transfusion,
B J Grossman, and
N C Stewart, and
A J Grindon
December 1980,
Journal of virological methods,
B J Grossman, and
N C Stewart, and
A J Grindon
May 2001,
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
B J Grossman, and
N C Stewart, and
A J Grindon
September 1978,
Vox sanguinis,
B J Grossman, and
N C Stewart, and
A J Grindon
October 1983,
British medical journal (Clinical research ed.),
B J Grossman, and
N C Stewart, and
A J Grindon
August 1983,
Journal of clinical pathology,
B J Grossman, and
N C Stewart, and
A J Grindon
January 2001,
Transplantation proceedings,
B J Grossman, and
N C Stewart, and
A J Grindon
January 1985,
Vox sanguinis,
